HPAI testing improvements suspended after HHS staffing cuts

The U.S. Food and Drug Administration is suspending efforts to improve testing for highly pathogenic avian influenza due to staffing cuts throughout the Department of Health and Human Services, according to a Reuters report.

Fda
JHVEPhoto | BigStock.com

The U.S. Food and Drug Administration (FDA) is suspending efforts to improve testing for highly pathogenic avian influenza (HPAI) due to staffing cuts throughout the Department of Health and Human Services (HHS), according to a Reuters report.

Log in to view the full article
Page 1 of 59
Next Page